Arrowstreet Capital, Limited Partnership Cytokinetics Inc Transaction History

Arrowstreet Capital, Limited Partnership

  • $121 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$18.57 - $25.68 $578,826 - $800,445
-31,170 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$15.26 - $28.61 $475,654 - $891,773
31,170 New
31,170 $648,000
Q1 2020

May 15, 2020
SELL
$8.75 - $16.3 $630,875 - $1.18 Million
-72,100 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$7.95 - $11.84 $573,195 - $853,664
72,100 New
72,100 $765,000

Others Institutions Holding CYTK

# of Institutions
409
Shares Held
125M
Call Options Held
4.55M
Put Options Held
2.42M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $3.91B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email